Which has the lower trailing P/E, CARE or DMII?

CARE has the lower trailing P/E: CARE trades at 5.16 and DMII at 34.76. P/E is one valuation measure and does not by itself establish which business is cheaper.

Does CARE or DMII pay a bigger dividend?

CARE pays a dividend (0.65% yield), while DMII has no payments in the available dividend history.

Is CARE or DMII more profitable?

CARE runs the higher net margin — CARE at 36.89% versus DMII at 0.00%.

Carter Bankshares, Inc. (CARE) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

A side-by-side comparison of Carter Bankshares, Inc. and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CARE

Carter Bankshares, Inc.

$673M

$30.37Financial ServicesDelayed quote: Oct 6, 2026, 12:25 PM EDT

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

$649M

$10.19Financial ServicesDelayed quote: Oct 6, 2026, 12:19 PM EDT

Total return — CARE vs DMII

growth of $100 · dividends reinvested · last 1y

CARE +66.0% (+66.0%/yr)DMII +3.1% (+3.1%/yr)CARE compounded faster over this window

CARE DMII

CARE vs DMII: by the numbers

•CARE is the larger company ($673M vs $649M market cap).
•CARE trades at the lower trailing earnings multiple (5.16 vs 34.76 P/E), one valuation lens rather than an overall verdict.
•CARE is profitable (36.89% net margin) while DMII runs a net loss (0.00%).
•CARE pays a dividend (0.65% yield), while DMII has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CARE	DMII
P/E ratio	5.16	34.76
Forward P/E	5.02	N/A
P/S ratio	1.93	N/A
P/B ratio	1.25	1.31

Profitability

Metric	CARE	DMII
Gross margin	N/A	0.00%
Operating margin	15.71%	0.00%
Net margin	36.89%	0.00%
ROE	23.85%	2.62%
ROIC	N/A	-0.28%

Carter Bankshares, Inc.: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Dividends

Metric	CARE	DMII
Dividend yield	0.65%	N/A
Payout ratio	3.40%	N/A

Growth (annualized)

Metric	CARE	DMII
Revenue CAGR (5Y)	17.25%	N/A
Total return CAGR (5Y)	15.68%	N/A

Frequently asked

Which has the lower trailing P/E, CARE or DMII?: CARE has the lower trailing P/E: CARE trades at 5.16 and DMII at 34.76. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does CARE or DMII pay a bigger dividend?: CARE pays a dividend (0.65% yield), while DMII has no payments in the available dividend history.
Is CARE or DMII more profitable?: CARE runs the higher net margin — CARE at 36.89% versus DMII at 0.00%.

Go deeper

Full CARE analysis Full DMII analysis Interactive comparison tool

Dig into the metrics

Carter Bankshares P/E ratio Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratio Carter Bankshares dividend yield Carter Bankshares ROE Drugs Made In America Acquisition II Corp. Ordinary Shares ROE Carter Bankshares operating margin Drugs Made In America Acquisition II Corp. Ordinary Shares operating margin Carter Bankshares revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares free cash flow

Carter Bankshares & Drugs Made In America Acquisition II Corp. Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.